SARS-CoV-2对生育的影响

doi:10.12280/gjszjk.20220314

摘要/Abstract

摘要：

近年严重急性呼吸综合征冠状病毒2（severe acute respiratory syndrome corona virus 2，SARS-CoV-2）大流行对人类健康造成了威胁。研究表明，SARS-CoV-2对人类生育能力有潜在影响，对男性生育力的影响远大于女性。目前研究表明接种疫苗可能不会对人类的生育能力存在不利影响。感染SARS-CoV-2会不会发生性传播、垂直传播及母婴传播，从而对下一代产生影响，目前暂不清楚。尚需要从生殖医学科、传染病学科角度探讨SARS-CoV-2及其疫苗对生育的影响，并讨论可能存在的性传播、垂直传播和母婴传播，以提高对SARS-CoV-2及其疫苗的认识。

关键词: SARS病毒, 生育力, 疾病传播，传染性, 传染性疾病传播，垂直, 疫苗

Abstract:

In recent years, the severe respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has posed a threat to human health. Studies have shown that SARS-CoV-2 has a potential effect on human fertility, and the effect on male fertility was much more than that on female fertility. Current researches have suggested that SARS-CoV-2 vaccination may not adversely affect fertility in humans. It is unclear whether SARS-CoV-2 infection can be transmitted sexually, vertically or from mother to child, and thus affect the next generation. It is necessary to explore the effects of SARS-CoV-2 and its vaccine on fertility from the perspectives of reproductive medicine and infectious diseases, and to discuss the possible sexual transmission, vertical transmission and mother-to-child transmission, so as to improve the understanding of SARS-CoV-2 and its vaccine.

Key words: SARS virus, Fertility, Disease transmission, infectious, Infectious disease transmission, vertical, Vaccines

叶玲, 马雪影, 王晓慧. SARS-CoV-2对生育的影响[J]. 国际生殖健康/计划生育, 2022, 41(6): 482-486.

YE Ling, MA Xue-ying, WANG Xiao-hui. Impact of SARS-CoV-2 on Reproduction[J]. Journal of International Reproductive Health/Family Planning, 2022, 41(6): 482-486.

参考文献 35

[1]	Tariq J, Chatterjee T, Andreoli L, et al. COVID-19 and fertility-at the crossroads of autoimmunity and thrombosis[J]. Rheumatol Int, 2021, 41(11):1885-1894. doi: 10.1007/s00296-021-04977-2. doi: 10.1007/s00296-021-04977-2 URL
[2]	Jing Y, Run-Qian L, Hao-Ran W, et al. Potential influence of COVID-19/ACE2 on the female reproductive system[J]. Mol Hum Reprod, 2020, 26(6):367-373. doi: 10.1093/molehr/gaaa030. doi: 10.1093/molehr/gaaa030 pmid: 32365180
[3]	Li R, Yin T, Fang F, et al. Potential risks of SARS-CoV-2 infection on reproductive health[J]. Reprod Biomed Online, 2020, 41(1):89-95. doi: 10.1016/j.rbmo.2020.04.018. doi: S1472-6483(20)30229-7 pmid: 32466994
[4]	Chen F, Zhu S, Dai Z, et al. Effects of COVID-19 and mRNA vaccines on human fertility[J]. Hum Reprod, 2021, 37(1):5-13. doi: 10.1093/humrep/deab238. doi: 10.1093/humrep/deab238 URL
[5]	Fan C, Lu W, Li K, et al. ACE2 Expression in Kidney and Testis May Cause Kidney and Testis Infection in COVID-19 Patients[J]. Front Med(Lausanne), 2020, 7:563893. doi: 10.3389/fmed.2020.563893. doi: 10.3389/fmed.2020.563893
[6]	Tal R, Seifer DB. Ovarian reserve testing: a user′s guide[J]. Am J Obstet Gynecol, 2017, 217(2):129-140. doi: 10.1016/j.ajog.2017.02.027. doi: 10.1016/j.ajog.2017.02.027 URL
[7]	Ding T, Wang T, Zhang J, et al. Analysis of Ovarian Injury Associated With COVID-19 Disease in Reproductive-Aged Women in Wuhan, China: An Observational Study[J]. Front Med(Lausanne), 2021, 8:635255. doi: 10.3389/fmed.2021.635255. doi: 10.3389/fmed.2021.635255
[8]	Li K, Chen G, Hou H, et al. Analysis of sex hormones and menstruation in COVID-19 women of child-bearing age[J]. Reprod Biomed Online, 2021, 42(1):260-267. doi: 10.1016/j.rbmo.2020.09.020. doi: 10.1016/j.rbmo.2020.09.020 pmid: 33288478
[9]	Carneiro Gomes PR, Rodrigues da Rocha MD, da Rocha Coelho FA, et al. Alterations of the male and female reproductive systems induced by COVID-19[J]. Wien Klin Wochenschr, 2021, 133(17/18):966-972. doi: 10.1007/s00508-021-01875-2. doi: 10.1007/s00508-021-01875-2 URL
[10]	Kaya Y, Kaya C, Tahta T, et al. Examination of the effect of COVID-19 on sexual dysfunction in women[J]. Int J Clin Pract, 2021, 75(3):e13923. doi: 10.1111/ijcp.13923. doi: 10.1111/ijcp.13923
[11]	Xu J, Qi L, Chi X, et al. Orchitis: a complication of severe acute respiratory syndrome (SARS)[J]. Biol Reprod, 2006, 74(2):410-416. doi: 10.1095/biolreprod.105.044776. doi: 10.1095/biolreprod.105.044776 pmid: 16237152
[12]	Chen F, Lou D. Rising Concern on Damaged Testis of COVID-19 Patients[J]. Urology, 2020, 142:42. doi: 10.1016/j.urology.2020.04.069. doi: 10.1016/j.urology.2020.04.069 URL
[13]	Yang M, Chen S, Huang B, et al. Pathological Findings in the Testes of COVID-19 Patients: Clinical Implications[J]. Eur Urol Focus, 2020, 6(5):1124-1129. doi: 10.1016/j.euf.2020.05.009. doi: S2405-4569(20)30144-9 pmid: 32563676
[14]	Batiha O, Al-Deeb T, Al-Zoubi E, et al. Impact of COVID-19 and other viruses on reproductive health[J]. Andrologia, 2020, 52(9):e13791. doi: 10.1111/and.13791. doi: 10.1111/and.13791
[15]	Kaur G, Thompson LA, Dufour JM. Sertoli cells--immunological sentinels of spermatogenesis[J]. Semin Cell Dev Biol, 2014, 30:36-44. doi: 10.1016/j.semcdb.2014.02.011. doi: 10.1016/j.semcdb.2014.02.011 pmid: 24603046
[16]	Gagliardi L, Bertacca C, Centenari C, et al. Orchiepididymitis in a Boy With COVID-19[J]. Pediatr Infect Dis J, 2020, 39(8):e200-e202. doi: 10.1097/INF.0000000000002769. doi: 10.1097/INF.0000000000002769 URL
[17]	Ma L, Xie W, Li D, et al. Effect of SARS-CoV-2 infection upon male gonadal function: A single center-based study[M]. Cold Spring Harbor Laboratory Press, 2020. doi: 10.1101/2020.03.21.20037267. doi: 10.1101/2020.03.21.20037267
[18]	Salonia A, Pontillo M, Capogrosso P, et al. Severely low testosterone in males with COVID-19: A case-control study[J]. Andrology, 2021, 9(4):1043-1052. doi: 10.1111/andr.12993. doi: 10.1111/andr.12993 pmid: 33635589
[19]	Holtmann N, Edimiris P, Andree M, et al. Assessment of SARS-CoV-2 in human semen-a cohort study[J]. Fertil Steril, 2020, 114(2):233-238.doi:10.1016/j.fertnstert.2020.05.028. doi: S0015-0282(20)30519-7 pmid: 32650948
[20]	Song C, Wang Y, Li W, et al. Absence of 2019 novel coronavirus in semen and testes of COVID-19 patients?[J]. Biol Reprod, 2020, 103(1):4-6. doi: 10.1093/biolre/ioaa050. doi: 10.1093/biolre/ioaa050 pmid: 32297920
[21]	Li D, Jin M, Bao P, et al. Clinical Characteristics and Results of Semen Tests Among Men With Coronavirus Disease 2019[J]. JAMA Netw Open, 2020, 3(5):e208292. doi: 10.1001/jamanetworkopen.2020.8292. doi: 10.1001/jamanetworkopen.2020.8292 URL
[22]	Gacci M, Coppi M, Baldi E, et al. Semen impairment and occurrence of SARS-CoV-2 virus in semen after recovery from COVID-19[J]. Hum Reprod, 2021, 36(6):1520-1529. doi: 10.1093/humrep/deab026. doi: 10.1093/humrep/deab026 URL
[23]	Vogels C, Brito AF, Wyllie AL, et al. Analytical sensitivity and efficiency comparisons of SARS-CoV-2 RT-qPCR primer-probe sets[J]. Nat Microbiol, 2020, 5(10):1299-1305. doi: 10.1038/s41564-020-0761-6. doi: 10.1038/s41564-020-0761-6 pmid: 32651556
[24]	Schwartz DA. An Analysis of 38 Pregnant Women With COVID-19, Their Newborn Infants, and Maternal-Fetal Transmission of SARS-CoV-2: Maternal Coronavirus Infections and Pregnancy Outcomes[J]. Arch Pathol Lab Med, 2020, 144(7):799-805. doi: 10.5858/arpa.2020-0901-SA. doi: 10.5858/arpa.2020-0901-SA URL
[25]	Chen H, Guo J, Wang C, et al. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records[J]. Lancet, 2020, 395(10226):809-815. doi: 10.1016/S0140-6736(20)30360-3. doi: S0140-6736(20)30360-3 pmid: 32151335
[26]	Sharma I, Kumari P, Sharma A, et al. SARS-CoV-2 and the reproductive system: known and the unknown..!![J]. Middle East Fertil Soc J, 2021, 26(1):1. doi: 10.1186/s43043-020-00046-z. doi: 10.1186/s43043-020-00046-z URL
[27]	Dong L, Tian J, He S, et al. Possible Vertical Transmission of SARS-CoV-2 From an Infected Mother to Her Newborn[J]. JAMA, 2020, 323(18):1846-1848. doi: 10.1001/jama.2020.4621. doi: 10.1001/jama.2020.4621 pmid: 32215581
[28]	Baud D, Greub G, Favre G, et al. Second-Trimester Miscarriage in a Pregnant Woman With SARS-CoV-2 Infection[J]. JAMA, 2020, 323(21):2198-2200. doi: 10.1001/jama.2020.7233. doi: 10.1001/jama.2020.7233 pmid: 32352491
[29]	Penfield CA, Brubaker SG, Limaye MA, et al. Detection of severe acute respiratory syndrome coronavirus 2 in placental and fetal membrane samples[J]. Am J Obstet Gynecol MFM, 2020, 2(3):100133. doi: 10.1016/j.ajogmf.2020.100133. doi: 10.1016/j.ajogmf.2020.100133 URL
[30]	Centeno-Tablante E, Medina-Rivera M, Finkelstein JL, et al. Transmission of SARS-CoV-2 through breast milk and breastfeeding: a living systematic review[J]. Ann N Y Acad Sci, 2021, 1484(1):32-54. doi: 10.1111/nyas.14477. doi: 10.1111/nyas.14477 URL
[31]	Pereira A, Cruz-Melguizo S, Adrien M, et al. Breastfeeding mothers with COVID-19 infection: a case series[J]. Int Breastfeed J, 2020, 15(1):69. doi: 10.1186/s13006-020-00314-8. doi: 10.1186/s13006-020-00314-8 pmid: 32770999
[32]	Gonzalez DC, Nassau DE, Khodamoradi K, et al. Sperm Parameters Before and After COVID-19 mRNA Vaccination[J]. JAMA, 2021, 326(3):273-274. doi: 10.1001/jama.2021.9976. doi: 10.1001/jama.2021.9976 pmid: 34137808
[33]	Safrai M, Herzberg S, Imbar T, et al. The BNT162b2 mRNA Covid-19 vaccine does not impair sperm parameters[J]. Reprod Biomed Online, 2022, 44(4):685-688. doi: 10.1016/j.rbmo.2022.01.008. doi: 10.1016/j.rbmo.2022.01.008 URL
[34]	Bentov Y, Beharier O, Moav-Zafrir A, et al. Ovarian follicular function is not altered by SARS-CoV-2 infection or BNT162b2 mRNA COVID-19 vaccination[J]. Hum Reprod, 2021, 36(9):2506-2513. doi: 10.1093/humrep/deab182. doi: 10.1093/humrep/deab182 URL
[35]	Orvieto R, Noach-Hirsh M, Segev-Zahav A, et al. Does mRNA SARS-CoV-2 vaccine influence patients′ performance during IVF-ET cycle?[J]. Reprod Biol Endocrinol, 2021, 19(1):69. doi: 10.1186/s12958-021-00757-6. doi: 10.1186/s12958-021-00757-6 URL